These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 32218846)

  • 21. MicroRNA-26a-5p inhibits proliferation, invasion and metastasis by repressing the expression of Wnt5a in papillary thyroid carcinoma.
    Shi D; Wang H; Ding M; Yang M; Li C; Yang W; Chen L
    Onco Targets Ther; 2019; 12():6605-6616. PubMed ID: 31496749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miRNA-15a regulates the proliferation and apoptosis of papillary thyroid carcinoma via regulating AKT pathway.
    Jin J; Zhang J; Xue Y; Luo L; Wang S; Tian H
    Onco Targets Ther; 2019; 12():6217-6226. PubMed ID: 31496725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interplay of TGFβ signaling and microRNA in thyroid cell loss of differentiation and cancer progression.
    Fuziwara CS; Saito KC; Kimura ET
    Arch Endocrinol Metab; 2019; 63(5):536-544. PubMed ID: 31482959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LncRNA LINC-PINT Inhibits Cancer Cell Proliferation, Invasion, and Migration in Osteosarcoma by Downregulating miRNA-21.
    Liu W
    Cancer Biother Radiopharm; 2019 May; 34(4):258-263. PubMed ID: 31070482
    [No Abstract]   [Full Text] [Related]  

  • 25. In Silico Integration Approach Reveals Key MicroRNAs and Their Target Genes in Follicular Thyroid Carcinoma.
    Hu S; Liao Y; Zheng J; Gou L; Regmi A; Zafar MI; Chen L
    Biomed Res Int; 2019; 2019():2725192. PubMed ID: 31032340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LINC01287/miR-298/STAT3 feedback loop regulates growth and the epithelial-to-mesenchymal transition phenotype in hepatocellular carcinoma cells.
    Mo Y; He L; Lai Z; Wan Z; Chen Q; Pan S; Li L; Li D; Huang J; Xue F; Che S
    J Exp Clin Cancer Res; 2018 Jul; 37(1):149. PubMed ID: 30001751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RETRACTED: MicroRNA-298 represses hepatocellular carcinoma progression by inhibiting CTNND1-mediated Wnt/β-catenin signaling.
    Cao N; Mu L; Yang W; Liu L; Liang L; Zhang H
    Biomed Pharmacother; 2018 Oct; 106():483-490. PubMed ID: 29990836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-143-3p targeting of ITGA6 suppresses tumour growth and angiogenesis by downregulating PLGF expression via the PI3K/AKT pathway in gallbladder carcinoma.
    Jin YP; Hu YP; Wu XS; Wu YS; Ye YY; Li HF; Liu YC; Jiang L; Liu FT; Zhang YJ; Hao YJ; Liu XY; Liu YB
    Cell Death Dis; 2018 Feb; 9(2):182. PubMed ID: 29416013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-298 inhibits malignant phenotypes of epithelial ovarian cancer by regulating the expression of EZH2.
    Zhou F; Chen J; Wang H
    Oncol Lett; 2016 Nov; 12(5):3926-3932. PubMed ID: 27895750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclin-dependent kinase 6 is a chromatin-bound cofactor for NF-κB-dependent gene expression.
    Handschick K; Beuerlein K; Jurida L; Bartkuhn M; Müller H; Soelch J; Weber A; Dittrich-Breiholz O; Schneider H; Scharfe M; Jarek M; Stellzig J; Schmitz ML; Kracht M
    Mol Cell; 2014 Jan; 53(2):193-208. PubMed ID: 24389100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Knockdown of CDK6 enhances glioma sensitivity to chemotherapy.
    Li B; He H; Tao BB; Zhao ZY; Hu GH; Luo C; Chen JX; Ding XH; Sheng P; Dong Y; Zhang L; Lu YC
    Oncol Rep; 2012 Sep; 28(3):909-14. PubMed ID: 22736304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potentially functional polymorphisms in cell cycle genes and the survival of non-small cell lung cancer in a Chinese population.
    Ma H; Chen J; Pan S; Dai J; Jin G; Hu Z; Shen H; Shu Y
    Lung Cancer; 2011 Jul; 73(1):32-7. PubMed ID: 21145615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell cycle activation in postmitotic neurons is essential for DNA repair.
    Schwartz EI; Smilenov LB; Price MA; Osredkar T; Baker RA; Ghosh S; Shi FD; Vollmer TL; Lencinas A; Stearns DM; Gorospe M; Kruman II
    Cell Cycle; 2007 Feb; 6(3):318-29. PubMed ID: 17297309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. From cell cycle to differentiation: an expanding role for cdk6.
    Grossel MJ; Hinds PW
    Cell Cycle; 2006 Feb; 5(3):266-70. PubMed ID: 16410727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma.
    Mendrzyk F; Radlwimmer B; Joos S; Kokocinski F; Benner A; Stange DE; Neben K; Fiegler H; Carter NP; Reifenberger G; Korshunov A; Lichter P
    J Clin Oncol; 2005 Dec; 23(34):8853-62. PubMed ID: 16314645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of p19INK4d, CDK4, CDK6 in glioblastoma multiforme.
    Lam PY; Di Tomaso E; Ng HK; Pang JC; Roussel MF; Hjelm NM
    Br J Neurosurg; 2000 Feb; 14(1):28-32. PubMed ID: 10884881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of G1 kinase activity for cdk6, a novel cyclin D partner.
    Meyerson M; Harlow E
    Mol Cell Biol; 1994 Mar; 14(3):2077-86. PubMed ID: 8114739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of CDK6 regulated by miR-298 on proliferation and apoptosis of thyroid cancer cells.
    Li X; Liu C; Zhao X; Wang R; Gu N; Shen H; Li X; Wang L; Li C
    Oncol Lett; 2020 Apr; 19(4):2909-2915. PubMed ID: 32218846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 2.